Our client Alydia Health received #FDA clearance of the Jada System and announced the publication of their pivotal PEARLE Study – two huge achievements in one week! Congrats to the team in their efforts
All eyes are on H+C clients Gyroscope Therapeutics and Sight Sciences, Inc.! Gyroscope was granted #510k clearance of its Orbit Subretinal Delivery System and Sight Sciences announced positive interim clinical results on the OMNI
Join us in congratulating ENDPOINT HEALTH. Launching out of stealth today, this H+C client is the first company founded to develop targeted therapeutics for #criticalillnesses including #sepsis, #ARDS and #COVID19. Katie Jennings at Forbes has the exclusive, read more here: https://bit.ly/2OmcIJ6.
We love working with MedTech Innovator and the best-in-class #medtech startups participating in its annual Showcase and Accelerator program. Today the organization announced the Top 50 #startups in this year’s cohort, which prominently features the industry’s
Congratulations to the team at January.ai on data presented at the American Diabetes Association Scientific Sessions in support of their new, personalized program for people with diabetes! More to explore here: https://lnkd.in/ga8vEVm #ADA2020 #Diabetes
A great way to start off our week 👏 Today, H+C client Sarepta Therapeutics announced positive clinical results from its investigational #genetherapy for the treatment of #limbgirdle #musculardystrophy Type 2E, one of the many subtypes of LGMD
Cheers to H+C client argenx for announcing results of their first Phase 3 clinical trial. 👏 Positive results demonstrated significant improvements in the daily living activities of certain patients living with
Select health systems combating #COVID19 are facing immense challenges as the demand for critical equipment surpasses available supply. We’re honored to work with amazing clients like CHF Solutions, Inc. who are offering technology to